Rosa Biotech win award at the Royal Society of Chemistry Emerging Technologies competition
Rosa Biotech has been named one of the most exciting health innovators in Europe after winning a Royal Society of Chemistry (RSC) Emerging Technologies 2019 award for its biosensing platform. The company has been awarded £10,000 prize money to help develop its technology.
The competition was part of the RSC’s Chemistry Means Business event which brings together pioneers, entrepreneurs and industry leaders for an innovation showcase in the chemical science sector across the UK and Europe. It involved a rigorous application process in which applicants had to put forward their ideas to improve lives across the Health, Food and Drink, Enabling Technologies and Energy and Environment sectors. 37 innovators, including Rosa Biotech, were shortlisted as finalists and invited to pitch to a panel of judges.
Andy (our CEO) and Jordan (our principal scientist) attended the awards ceremony in London on 28th October. Andy's pitch went down well with the audience and judges, with Rosa winning the health category, alongside Rubynanomed (a Portugal based startup)..
Andy gave an interview after the award was announced, saying: “It’s a really incredible validation to be recognised with this prestigious award from the Royal Society of Chemistry. It is especially amazing for us because we’re such an early company.”
Aurora Antemir, Head of Industry at the Royal Society of Chemistry said: “Chemistry Means Business pairs the next generation of chemistry innovators with the blue-chip companies that can take their ideas forward. Both the winners and finalists this year have undoubtedly been amongst the most innovative we’ve seen yet. We’re looking forward to seeing how these incredible new ideas and innovations will deliver really exciting real-world benefits."
Now in its seventh year, the competition brings cutting-edge science to the real world for the benefit of society. Previous winners have gone on to raise a combined total of over £32m in equity investment and grant funding, with one company subsequently being sold for £28m. Winners have also expanded overseas, entered commercial contracts, conducted clinical and industrial scale trials, and collectively doubled their staff.
Rosa will receive £10,000 support from competition partners (Unilever, Pfizer, Johnson Matthey, RSSL and Croda) and intensive business and pitch training at Cambridge Judge Business school.